- 1Individual_Sketch_Social-01 (2021-1653/1/1/1)
2020, item - 2Individual_Sketch_Social-02 (2021-1653/1/1/2)
2020, item - 3Individual_Sketch_Social-03 (2021-1653/1/1/3)
2020, item - 4Individual_Sketch_Social-03V2 (2021-1653/1/1/4)
2020, item - 5PrototypeSketch (2021-1653/1/1/5)
2020, item - 6Set of graphics showing the Virustatic Shield design in use (2021-1653/3/1/2)
2020, sub-sub-series - 7Design in use graphic on red branded background (2021-1653/3/1/2/1)
2020, item - 8Design in use graphic on white branded background (2021-1653/3/1/2/2)
2020, item - 9Digital marketing and promotional material relating to the Virferrin protein (2021-1653/3/2)
2020-2021, sub-series - 10Viruferrin � logo and information (2021-1653/3/2/1)
2020-2021, sub-sub-series - 11Viruferrin_Logo (2021-1653/3/2/1/1)
2020, item - 12FINAL_Viruferrin_Document (2021-1653/3/2/1/2)
2021, item - 13Set of graphics showing how the Viruferrin protein works (2021-1653/3/2/2)
2 February 2021, sub-sub-series - 14Virustatic Binding (2021-1653/3/2/2/1)
2 February 2021, item - 15Virustatic Brownian Motion (2021-1653/3/2/2/2)
2 February 2021, item